Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lambda-X is a Belgian optical engineering and manufacturing company that designs, develops, qualifies, and produces high-precision optical and metrology systems for life sciences, medical, industrial, space, and defense applications. In healthcare and life sciences, the company supports biopharmaceutical process control, in vitro diagnostics, clinical imaging, cell therapy, and academic research with custom optical instruments and subsystems. Lambda-X also built a proprietary ophthalmic metrology business around its NIMO product family for intraocular, contact, and spectacle lens characterization. Since 2024, the core high-tech optics business has been fully integrated into the Verhaert group, while the ophthalmic division was spun out as Lambda-X Ophthalmics. The company operates as a commercial-stage provider of devices and enabling instrumentation rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lambda-X.